Skip to main content
SpringerLink
Log in

A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy

  • Original Research
  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Background

DepoFoam® bupivacaine (Pacira Pharmaceuticals, Inc., San Diego, CA, USA), an extended-release liposomal bupivacaine-based analgesic, was compared with placebo for the prevention of pain after bunionectomy in a randomized, multicenter, double-blind phase 3 clinical study.

Methods

Patients received placebo (n=96) or DepoFoam bupivacaine 120 mg (n=97) via wound infiltration prior to closure. Pain intensity was assessed using a numeric rating scale (NRS) from time 0 through to 72 hours postsurgically. The primary efficacy measure was area under the curve (AUC) of NRS scores through 24 hours. Other efficacy measures included AUC of NRS at other time points, proportion of patients who were pain-free, time to first opioid use, and total postsurgical consumption of supplemental opioid medication. Adverse events were also assessed.

Results

The AUC for NRS scores was significantly less in patients treated with DepoFoam bupivacaine versus patients receiving placebo at 24 hours (P=0.0005) and 36 hours (P<0.0229). More patients treated with DepoFoam bupivacaine avoided use of opioid rescue medication during the first 24 hours (7.2% vs. 1%; P<0.0404) and were pain-free (NRS ≤1) at 2, 4, 8, and 48 hours. Median time-to-first-opioid use was delayed in favor of DepoFoam bupivacaine (4.3 vs. 7.2 hours; P<0.0001). Fewer adverse events were reported by patients treated with DepoFoam bupivacaine (59.8%) versus placebo (67.7%).

Conclusions

DepoFoam bupivacaine, a long-acting local analgesic, provided extended pain relief and decreased opioid use after bunionectomy, compared with placebo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2004;100:1573–1581.

    Article  Google Scholar 

  2. Crews JC. Epidural opioid analgesia. Crit Care Clin. 1990;6:315–342.

    PubMed  CAS  Google Scholar 

  3. White PF, Sacan O, Tufanogullari B, Eng M, Nuangchamnong N, Ogunnaike B. Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery. Can J Anaesth. 2007;54:342–348.

    Article  PubMed  Google Scholar 

  4. Kehlet H. Postoperative opioid sparing to hasten recovery: what are the issues? Anesthesiology. 2005;102:1083–1085.

    Article  PubMed  Google Scholar 

  5. Jirasiritham S, Tantivitayatan K, Jirasiritham S. Perianal blockage with 0.5% bupivacaine for postoperative pain relief in hemorrhoidectomy. J Med Assoc Thai. 2004;87:660–664.

    PubMed  Google Scholar 

  6. Chester JF, Stanford BJ, Gazet JC. Analgesic benefit of locally injected bupivacaine after hemorrhoidectomy. Dis Colon Rectum. 1990;33:487–489.

    Article  PubMed  CAS  Google Scholar 

  7. Vinson-Bonnet B, Coltat JC, Fingerhut A, Bonnet F. Local infiltration with ropivacaine improves immediate postoperative pain control after hemorrhoidal surgery. Dis Colon Rectum. 2002;45:104–108.

    Article  PubMed  Google Scholar 

  8. Lohsiriwat D, Lohsiriwat V. Outpatient hemorrhoidectomy under perianal anesthetics infiltration. J Med Assoc Thai. 2005;88:1821–1824.

    PubMed  Google Scholar 

  9. Brunat G, Pouzeratte Y, Mann C, Didelot JM, Rochon JC, Eledjam JJ. Posterior perineal block with ropivacaine 0.75% for pain control during and after hemorrhoidectomy. Reg Anesth Pain Med. 2003;28:228–232.

    PubMed  CAS  Google Scholar 

  10. Marcaine [package insert]. Sodertalje, Sweden: AstraZeneca; 2010.

    Google Scholar 

  11. Viscusi ER, Sinatra S. The safety of Exparel, a multivesicular liposomal extended-release bupivacaine [abstract]. Presented at: the Annual Meeting of the International Anesthesia Research Society; May 21–24, 2011; Vancouver, Canada.

  12. Worrell JB, Barbour G. The Mayo block: an efficacious block for hallux and first metatarsal surgery. AANA J. 1996;64:146–152.

    PubMed  CAS  Google Scholar 

  13. Remadevi R, Szallisi A. Adlea (ALGRX-4975), an injectable capsaicin (TRPV1 receptor agonist) formulation for longlasting pain relief. IDrugs. 2008;11:120–132.

    PubMed  CAS  Google Scholar 

  14. Kehlet H, Dahl JB. The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth Analg. 1993;77:1048–1056.

    Article  PubMed  CAS  Google Scholar 

  15. White PF. The role of non-opioid analgesic techniques in the management of pain after ambulatory surgery. Anesth Analg. 2002;94:577–585.

    Article  PubMed  Google Scholar 

  16. Elvir-Lazo OL, White PF. The role of multimodal analgesia in pain management after ambulatory surgery. Curr Opin Anaesthesiol. 2010;23:697–703.

    Article  PubMed  Google Scholar 

  17. Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97:534–540.

    Article  PubMed  Google Scholar 

  18. Bramlett KW, Jones RK, Pink M, Pink T. A single administration of DepoBupivacaine intraoperatively provides analgesia and reduction in use of rescue opiates compared to bupivacaine HCL in patients undergoing total knee arthroplasty [abstract]. Presented at: the Biennial World Congress of the International College of Surgeons; December 3–6, 2008; Vienna, Austria.

  19. Miller H, Terem TM, Kheladze K, Mosidze B. A single administration of DepoBupivacaine intraoperatively provides three-day analgesia and reduction in use of rescue opioids in patients undergoing hemorrhoidectomy [abstract]. Presented at: Annual Meeting of the American Society of Colon and Rectal Surgeons; May 2–6, 2009;Florida, United States.

  20. Wang H, Gargano C, Lukac S, et al. An enhanced bunionectomy model as a potential tool for early decision-making in the development of new analgesics. Adv Ther. 2010;27:963–980.

    Article  PubMed  CAS  Google Scholar 

  21. Riff DS, Duckor S, Gottlieb I, et al. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, doubleblind, placebo-controlled study conducted over 5 days. Clin Ther. 2009;31:2072–2085.

    Article  PubMed  CAS  Google Scholar 

  22. Pollak R, Raymond GA, Jay RM, et al. Analgesic efficacy of valdecoxib for acute postoperative pain after bunionectomy. J Am Podiatr Med Assoc. 2006;96:393–407.

    PubMed  Google Scholar 

  23. Daniels SE, Baum DR, Clark F, Golf MH, McDonnell ME, Boesing SE. Diclofenac potassium liquid-filled soft gelatin capsules for the treatment of postbunionectomy pain. Curr Med Res Opin. 2010;26:2375–2384.

    Article  PubMed  CAS  Google Scholar 

  24. Apfelbaum JL, Desjardins PJ, Brown MT, Verburg KM. Multiple-day efficacy of parecoxib sodium treatment in postoperative bunionectomy pain. Clin J Pain. 2008;24:784–792.

    Article  PubMed  Google Scholar 

  25. Daniels SE, Upmalis D, Okamoto A, Lange C, Haeussler J. A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain. Curr Med Res Opin. 2009;25:765–776.

    Article  PubMed  CAS  Google Scholar 

  26. Daniels S, Casson E, Stegmann JU, et al. A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain. Curr Med Res Opin. 2009;25:1551–1561.

    Article  PubMed  CAS  Google Scholar 

  27. Daniels SE, Spivey RJ, Singla S, Golf M, Clark FJ. Efficacy and safety of oxycodone HCl/niacin tablets for the treatment of moderate-to-severe postoperative pain following bunionectomy surgery. Curr Med Res Opin. 2011;27:593–603.

    Article  PubMed  CAS  Google Scholar 

  28. Webster L, Richards P, Stern W, Kelen R. A doubleblind, placebo-controlled study of dual-opioid treatment with the combination of morphine plus oxycodone in patients with acute postoperative pain. J Opioid Manag. 2010;6:329–340.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Premier Clinical Research Centers, Austin, TX, USA

    Michael Golf & Stephen E. Daniels

  2. Pacira Pharmaceuticals, Inc., 5 Sylvan Way, Parsippany, NJ, 07054, USA

    Erol Onel

Authors
  1. Michael Golf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen E. Daniels
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erol Onel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erol Onel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Golf, M., Daniels, S.E. & Onel, E. A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Therapy 28, 776–788 (2011). https://doi.org/10.1007/s12325-011-0052-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12325-011-0052-y

Keywords

Search

Navigation